SANOFI US SERVICES INC. for SANOFI US SERVICES INC
What was lobbied
9 issue areas, each in the filer's own words, with who lobbied on it and where.
Torts TOR
General issues related to the reform of the Vaccine Injury Compensation Program (VICP)
Foreign entity interest: Sanofi US Services Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SEAN CALLINICOS | — |
| PATRICK MAYES MCLAIN | — |
Manufacturing MAN
All provisions of HR 3204 "Drug Quality and Security Act" and efforts to seek support for inclusion on the Department of Commerce Manufacturing Council
Foreign entity interest: Sanofi US Services Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SEAN CALLINICOS | — |
| TIMOTHY CLARK | — |
| MARYANNE DOLBEARE DUNLAP | — |
| PATRICK MAYES MCLAIN | — |
Taxation/Internal Revenue Code TAX
Issues related to corporate income tax reform; a strengthened and permanent U.S. R&D tax credit; extending and maintaining the orphan drug tax credit; and all provisions of HR 2835 and S1647 "Restoring Access to Medication Act of 2013"
Foreign entity interest: Sanofi US Services Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARYANNE DOLBEARE DUNLAP | — |
| PATRICK MAYES MCLAIN | — |
| ANN TAYLOR | — |
Copyright/Patent/Trademark CPT
All provisions of HR 2985 "Combination Drug Development Incentive Act of 2013" and all provisions of HR3309 "Innovation Act"
Foreign entity interest: Sanofi US Services Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SEAN CALLINICOS | — |
| PATRICK MAYES MCLAIN | — |
Economics/Economic Development ECN
All provisions of HR 2052 and S 1023 "Global Investment in American Jobs Act of 2013"
Foreign entity interest: Sanofi SA, the foreign parent corporation of Sanofi US Services Inc.
| Lobbyist | Covered position, as disclosed |
|---|---|
| PATRICK MAYES MCLAIN | — |
| ANN TAYLOR | — |
Health Issues HCR
Education and awareness of the 2013-2014 influenza season; education and awareness of pandemic and biodefense funding, including policy ramifications of recent BARDA contract awards; education and awareness of Dengue; general issues related to NIH funding; all provisions of HR 2094 "School Access to Emergency Epinephrine Act"; all provisions of HR2985 "The Combination Drug Development Incentive Act"; S1871 "Sustainable Growth Rate (SGR) Repeal and Medicare Beneficiary Access Improvement Act of2013"; and all provisions of HR1024 and S557 "Medication Therapy Management Empowerment Act of 2013"
Foreign entity interest: Sanofi US Services Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SEAN CALLINICOS | — |
| TIMOTHY CLARK | — |
| MARYANNE DOLBEARE DUNLAP | — |
| PATRICK MAYES MCLAIN | — |
Medicare/Medicaid MMM
Issues related to coverage and reimbursement for those who are covered by the Medicaid program and the Medicare program, including the Part D prescription drug benefit; general issues related to reform of the Medicare Part D program; and issues related to the Medicare Part B reimbursement of prescription drugs.
Foreign entity interest: Sanofi US Services Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SEAN CALLINICOS | — |
| TIMOTHY CLARK | — |
| MARYANNE DOLBEARE DUNLAP | — |
| PATRICK MAYES MCLAIN | — |
Budget/Appropriations BUD
The scoring of preventive health savings including all provisions of S1422 and HR 2663 "Preventative Health Savings Act" and H.J.Res.59 - Continuing Appropriations Resolution, 2014, including funding for FDA.
Foreign entity interest: Sanofi US Services Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SEAN CALLINICOS | — |
| TIMOTHY CLARK | — |
| PATRICK MAYES MCLAIN | — |
Animals ANI
Education and awareness regarding illegal compounding of veterinary drugs for animals and general issues related to animal vaccine lot release.
Foreign entity interest: Sanofi US Services Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARYANNE DOLBEARE DUNLAP | — |
| PATRICK MAYES MCLAIN | — |
Affiliated organisations
| Organisation | Location |
|---|---|
| SANOFI PASTEUR | Swiftwater, PA, US |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.